FGF2 and asthma: Moreover, intranasal administration of budesonide, a clinical medicine to treat asthma, was unable to suppress FGF2 overexpression in HDM-induced asthmatic mouse lungs, which might explain the clinical evidence of the correlation between FGF2 expression levels and asthma severity [6].